(Total Views: 190)
Posted On: 10/07/2019 8:55:44 AM
Post# of 107225

$SMMT News Article - Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole's Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection https://marketwirenews.com/news-releases/summ...15099.html


My Twitter: WhyteStocks